Loading...

Gabriel Mannis, MD

TitleAssistant Professor
SchoolUCSF School of Medicine
DepartmentMedicine
Address400 Parnassus Avenue
San Francisco CA 94117
Phone415-353-2421
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Harvard UniversityB.A.Romance Languages and Literature
    University of California, DavisM.D.
    University of California, San FranciscoInternship/Residency, Internal Medicine
    University of California, San FranciscoFellowship, Hematology/Oncology
    Collapse Awards and Honors
    2017UCSF Bridges Curriculum Teaching Award
    2014American Society of Hematology Research Training Award, Senior Investigator
    2013Edward S. Ageno Family Endowed Fellowship in Hematology
    2013UCSF Clinical Fellow Award, Hematology/Oncology Division
    2012UCSF Clinical Fellow Award, Hematology/Oncology Division
    2011UCSF Teaching Excellence Award for Cherished Housestaff (T.E.A.C.H.)
    2011UCSF Internal Medicine Professionalism Award
    2008UC Davis Ernest M. Gold Award for Excellence in Internal Medicine
    2007Alpha Omega Alpha Medical Honor Society
    2007Major C.W. Offutt VA Medical Center Award
    2005Howard Hughes Medical Institute (HHMI) - National Institutes of Health (NIH) Research Scholar
    2000Harvard College Scholarship

    Collapse Overview 

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Global Health

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Foley N, Van Ziffle J, Yu J, Qi Z, Grenert JP, Yeh I, Bastian B, Kogan S, Mannis GN. Acute myeloid leukemia with t(14;21) involving RUNX1 and SYNE2: A novel favorable-risk translocation? Cancer Genet. 2017 Oct; 216-217:74-78. PMID: 29025598.
      View in: PubMed
    2. Gupta NK, Wang CC, Mannis GN, Yu JJ, Rubenstein JL. Regression of methotrexate-resistant AIDS-related primary central nervous system lymphoma with lenalidomide plus combination anti-retroviral therapy. Leuk Lymphoma. 2017 Nov; 58(11):2748-2751. PMID: 28395565.
      View in: PubMed
    3. Eckhert EE, Schoenbeck KL, Galligan D, McNey LM, Hwang J, Mannis GN. Advance care planning and end-of-life care for patients with hematologic malignancies who die after hematopoietic cell transplant. Bone Marrow Transplant. 2017 Jun; 52(6):929-931. PMID: 28287642.
      View in: PubMed
    4. Gupta NK, Nolan A, Omuro A, Reid EG, Wang CC, Mannis G, Jaglal M, Chavez JC, Rubinstein PG, Griffin A, Abrams DI, Hwang J, Kaplan LD, Luce JA, Volberding P, Treseler PA, Rubenstein JL, et al. Long-term survival in AIDS-related primary central nervous system lymphoma. Neuro Oncol. 2017 Jan; 19(1):99-108. PMID: 27576871.
      View in: PubMed
    5. Mulé MP, Mannis G, Wood BL, Radich JP, Hwang J, Ramos NR, Andreadis C, Damon L, Logan AC, Martin TG, Hourigan CS, et al. Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2016 Nov; 22(11):1974-1982. PMID: 27544285.
      View in: PubMed
    6. Mannis TE, Mannis G, Waterhouse EG, Aldave AJ, Rose-Nussbaumer J. Paraproteinemic keratopathy as the presenting sign of hematologic malignancy. Am J Hematol. 2016 Sep; 91(9):961-2. PMID: 26872417.
      View in: PubMed
    7. Mannis G, Martin TG, Damon LE, Andreadis C, Olin RL, Kong KA, Faham M, Hwang J, Ai WZ, Gaensler KM, Sayre PH, Wolf JL, Logan AC. Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk after Autologous Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016 Jun; 22(6):1030-1036. PMID: 26899561.
      View in: PubMed
    8. Mannis G, McNey LM, Gupta NK, Gross DM. The transfusion tether: Bridging the gap between end-stage hematologic malignancies and optimal end-of-life care. Am J Hematol. 2016 Jun; 91(4):364-5. PMID: 26799788.
      View in: PubMed
    9. Mannis G, Martin TG, Damon LE, Logan AC, Olin RL, Flanders MD, Ai WZ, Gaensler KM, Kaplan LD, Sayre PH, Smith CC, Wolf JL, Andreadis C. Long-term outcomes of patients with intermediate-risk acute myeloid leukemia treated with autologous hematopoietic cell transplant in first complete remission. Leuk Lymphoma. 2016 Jul; 57(7):1560-6. PMID: 26490487.
      View in: PubMed
    10. Byrne M, Mannis GN, Nair J, Andreadis C. Inferior vena cava filter thrombosis. Clin Case Rep. 2016 Feb; 4(2):162-4. PMID: 26862415; PMCID: PMC4736520.
    11. Mannis GN, Andreadis C, Logan AC, Damon LE, Benet LZ, Ai WZ, Gaensler KM, Kaplan LD, Koplowicz YB, Linker CA, Olin RL, Sayre PH, Smith CC, Sudhindra A, Venstrom JM, Wolf JL, Martin TG. A phase I study of targeted, dose-escalated intravenous busulfan in combination with etoposide as myeloablative therapy for autologous stem cell transplantation in acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2015 Jun; 15(6):377-83. PMID: 25776193.
      View in: PubMed
    12. Mannis GN, Logan AC, Leavitt AD, Yanada M, Hwang J, Olin RL, Damon LE, Andreadis C, Ai WZ, Gaensler KM, Greene CC, Gupta NK, Kaplan LD, Mahindra A, Miyazaki Y, Naoe T, Ohtake S, Sayre PH, Smith CC, Venstrom JM, Wolf JL, Caballero L, Emi N, Martin TG. Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysis. Bone Marrow Transplant. 2015 Jan; 50(1):40-4. PMID: 25243620.
      View in: PubMed
    13. Mannis G, Wu D, Dea T, Mauro T, Hsu G. Ibrutinib rash in a patient with 17p del chronic lymphocytic leukemia. Am J Hematol. 2015 Feb; 90(2):179. PMID: 24890909; PMCID: PMC4548957.
    14. Rubenstein JL, Gupta NK, Mannis GN, Lamarre AK, Treseler P. How I treat CNS lymphomas. Blood. 2013 Oct 03; 122(14):2318-30. PMID: 23963042; PMCID: PMC3790503.
    15. Mannis GN, Fehniger JE, Creasman JS, Jacoby VL, Beattie MS. Risk-reducing salpingo-oophorectomy and ovarian cancer screening in 1077 women after BRCA testing. JAMA Intern Med. 2013 Jan 28; 173(2):96-103. PMID: 23247828; PMCID: PMC4989513.
    Gabriel's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP